While Th subsets are discussed broadly, the role of Th17/IL-17 in EC remains controversial, with both pro- and anti-tumor effects reported across studies; we revisit this debate in Section 3.1 when considering checkpoint regulation (17, 18). Here, IL17A is linked to neoplasm.